Global PCBA industry faces two core practical trends in mid-2026: split supply status of passive components and fast-growing orders from wearable medical electronics, greatly changing manufacturers' production and purchasing plans.
First, passive parts market shows obvious polarized shortage. Ordinary low-value MLCC, regular resistors for daily consumer goods keep stable supply with 6–10 weeks lead time. But high-capacity high-voltage MLCC, automotive-grade resistors and high-power inductors stay tight, mainly pulled by massive AI server and new energy vehicle orders. A single AI server uses 10 times more MLCC than regular server, pushing leading component makers to shift most production lines toward high-profit AI and auto parts. Lead time of these scarce items extends to 20–40 weeks, forcing many EMS factories to adjust BOM and select alternative qualified parts to avoid production suspension. Meanwhile, mainstream semiconductor brands rolled out round of price hikes from April 2026, lifting overall raw material cost for PCBA producers.
Second, wearable medical PCBA becomes a high-growth niche track. Global demand for portable health monitors, continuous glucose testers and ECG patch devices rises rapidly, requiring miniaturized, flexible and high-reliability circuit assembly. Unlike regular consumer PCBA, medical products need ISO13485 certification, full production traceability via MES system and strict conformal coating on rigid-flex boards. Most overseas medical clients prefer one-stop service including DFM check, rapid prototyping and finished PCBA testing, instead of separated patch processing only. Flexible FPC assembly turns into essential technical competitiveness for factories targeting medical customers.
In addition, small-batch prototype lead time gradually improves. Thanks to steady logistics and partial fab capacity expansion, common prototype delivery shortens from over two months to 2–3 weeks, good for clients launching new medical and smart wearable projects quickly.
Against such market changes, our PCBA company optimizes two key directions: build stable long-term cooperation with multiple component suppliers to ease material shortage risk, and upgrade flexible SMT production line to meet mini medical board assembly standards. We keep supporting global buyers on component substitution suggestion and certified medical-grade PCBA manufacturing amid current industry fluctuation.
